Then, we knocked down IGF2BP3 in HCC cells; IGF2BP3 expression was significantly reduced after the transfection of sh-IGF2BP3-1 or sh-IGF2BP3-2 (Supplementary Fig. 3c). Here, IGF2BP3 is linked to hepatocellular carcinoma.